Harvest One (CVE:HVT) Launches Satipharm Reformulated CBD Capsules in Europe
Harvest One (CVE:HVT) Launches Satipharm Reformulated CBD Capsules in Europe

Perth, Jan 30, 2019 AEST (ABN Newswire) - MMJ Group Holdings Limited (ASX:MMJ) (MMJJF:OTCMKTS) ("MMJ") is pleased to note the attached announcement by Harvest One Cannabis Inc. (CVE:HVT) (HRVOF:OTCMKTS) ("Harvest One") confirming that it has launched European sales of its recently reformulated Satipharm CBD capsules.

MMJ owns 55,557,994 shares in Harvest One for a 30.5% shareholding.

To view the announcement, please visit:

About MMJ Group Holdings Ltd

Phytotech Medical ASX:PYL

MMJ Group Holdings Ltd (ASX:MMJ) is a global cannabis investment company. MMJ owns a portfolio of minority investments and aims to invest across the full range of emerging cannabis-related sectors including healthcare, technology, infrastructure, logistics, processing, cultivation, equipment and retail. For MMJ's latest investor presentation and news, please visit: https://www.mmjphytotech.com.au/investors/



Investor and Media Enquiries:
Jason Conroy
Chief Executive Officer
T: +61-2-8098-0819
E: info@mmjgh.com.au

Related Companies

MMJ Group Holdings Ltd   
Harvest One Cannabis Inc

ABN Newswire
ABN Newswire This Page Viewed:  (Last 7 Days: 18) (Last 30 Days: 81) (Since Published: 7121)